← Human Trials & Peer-Reviewed Studies
The effects of the calcium-magnesium-bicarbonate content in thermal mineral water on chronic low back pain: a randomized, controlled follow-up study.
Plain-language guide to PMID 29322254 (2018): single-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 105 patients, chronic pain: fibromyalgia & crps.
Key Facts
- PMID
- 29322254
- Journal
- International journal of biometeorology
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Gáti T et al. (5 authors)
- DOI
- 10.1007/s00484-017-1491-1
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc in the context of chronic pain: fibromyalgia & crps.
The aim of this study was to investigate the effects of balneotherapy on chronic low back pain.
Why It Was Studied
This is a minimized, follow-up study evaluated according to the analysis of intention to treat.
The subjects included in the study were 105 patients suffering from chronic low back pain.
Who Took Part
The abstract describes 105 patients taking part.
PubMed indexes the participants as middle-aged adults and older adults, both men and women.
How the Study Was Run
The design is described as randomized and single-blind.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Only one side, usually the patients, was kept unaware of whether Vitamin D, K2, Magnesium and Zinc was given.
What Was Measured
This is a minimized, follow-up study evaluated according to the analysis of intention to treat.
The subject headings attached to it are Balneology, Bicarbonates, Chronic Disease, Low Back Pain, Magnesium, Mineral Waters and Pain Measurement.
Author keywords: Balneotherapy, Chronic low back pain, Controlled, Randomized trial and Thermal water.
What This Means in Plain Language
The paper is a randomized and single-blind study of Vitamin D, K2, Magnesium and Zinc in 105 patients in people with chronic pain: fibromyalgia & crps.
The publication is from 2018 (International journal of biometeorology), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Chronic pain: fibromyalgia & CRPS research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.